Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model

Journal of Virology

Volumn 86, Issue 21, 2012, Pages 11472-11482

  Schijf, Marcel A ^a,b   Kruijsen, Debby ^a   Bastiaans, Jacqueline ^b   Coenjaerts, Frank E J ^c   Garssen, Johan ^b,d   van bleek, Grada M ^a   van't Landa, Belinda ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OLIGOSACCHARIDE; PECTIN DERIVED ACIDIC OLIGOSACCHARIDE; PREBIOTIC AGENT; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DIET SUPPLEMENTATION; ENZYME ACTIVITY; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH1 CELL; TH1 TH2 BALANCE; VACCINATION; VIRAL CLEARANCE; VIRUS IMMUNITY;

ANIMALS; BODY WEIGHT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS VACCINES; DIET; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED C57BL; OLIGOSACCHARIDES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TH1 CELLS;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84869027322     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06708-11     Document Type: Article

References (60)

1. Arslanoglu S, et al. 2008. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr. 138:1091-1095.
2. Baru AM, et al. 2010. Selective depletion of Foxp3+ Treg during sensitization phase aggravates experimental allergic airway inflammation. Eur.J. Immunol. 40:2259-2266.
3. Beaty SR, Rose CE, Jr, Sung SS. 2007. Diverse and potent chemokine production by lung CD11bhigh dendritic cells in homeostasis and in allergic lung inflammation. J. Immunol. 178:1882-1895.
4. Becker Y. 2006. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review.Virus Genes 33:235-252.
5. Belderbos ME, et al. 2009. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin.Immunol. 133:228-237.
6. Bryan DL, Hart PH, Forsyth KD, Gibson RA. 2007. Immunomodulatory constituents of human milk change in response to infant bronchiolitis.Pediatr. Allergy Immunol. 18:495-502.
7. Castilow EM, Olson MR, Varga SM. 2007. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. Immunol. Res. 39:225-239.
8. Clarke TB, et al. 2010. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16:228-231.
9. de Filippo C, et al. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.Proc. Natl. Acad. Sci. U.S.A. 107:14691-14696.
10. de Swart RL, et al. 2002. Immunization of macaques with formalininactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. J. Virol. 76:11561-11569.
11. Eiwegger T, et al. 2010. Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties.Pediatr. Allergy Immunol. 21:1179 -1188.
12. Foti M, et al. 1999. Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. Int. Immunol. 11:979 -986.
13. Fujiwara D, et al. 2008. Systemic control of plasmacytoid dendritic cells byCD8+T cells and commensal microbiota. J. Immunol. 180:5843-5852.
14. Fulton RB, Meyerholz DK, Varga SM. 2010. Foxp3+CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratorysyncytial virus infection. J. Immunol. 185: 2382-2392.
15. Glezen WP, Taber LH, Frank AL, Kasel JA. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140:543-546.
16. Gori A, et al. 2011. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial. Mucosal Immunol. 5:544-563.
17. Gruber C, et al. 2010. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J. Allergy Clin. Immunol. 126:791-797.
18. Haanen JB, et al. 1999. Systemic T cell expansion during localized viral infection. Eur. J. Immunol. 29:1168-1174.
19. Houben ML, et al. 2010. Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J. Med. Virol.82:1266-1271.
20. Hummelen R, Vos AP, van't Land B, van Norren K, Reid G. 2010.Altered host-microbe interaction in HIV: a target for intervention with pro- and prebiotics. Int. Rev. Immunol. 29:485-513.
21. Ichinohe T, et al. 2011. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U.S.A. 108:5354-5359.
22. Jessen B, Faller S, Krempl CD, Ehl S. 2011. Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection. J. Virol. 85:10135-10143.
23. Koenig JE, et al. 2011. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1):4578-4585.
24. Kruijsen D, et al. 2010. Serum antibodies critically affect virus-specific CD4+/CD8+T cell balance during respiratory syncytial virus infections. J. Immunol. 185:6489-6498.
25. Kruijsen D, et al. 2011. Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV. Vaccine 29:2730-2741.
26. Lee DC, et al. 2010. CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J. Virol. 84:8790-8798.
27. Loebbermann J, et al. 2012. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 5:161-172.
28. Lukens MV, et al. 2006. Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology 352:157-168.
29. Lukens MV, Kruijsen D, Coenjaerts FE, Kimpen JL, van Bleek GM. 2009. Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lungdraining lymph node. J. Virol. 83:7235-7243.
30. Ly NP, Litonjua A, Gold DR, Celedon JC. 2011. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J. Allergy Clin. Immunol. 127:1087-1094.
31. Martinez FD. 2003. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr. Infect. Dis. J. 22:S76-S82.
32. Maslowski KM, Mackay CR. 2011. Diet, gut microbiota and immune responses. Nat. Immunol. 12:5-9.
33. Moro G, et al. 2002. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J. Pediatr. Gastroenterol. Nutr. 34:291-295.
34. Olson MR, Hartwig SM, Varga SM. 2008. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. J. Immunol. 181:7958-7968.
35. Olson MR, Varga SM. 2007. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. J. Immunol. 179:5415-5424.
36. Olson MR, Varga SM. 2008. Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. Expert Rev. Vaccines 7:1239-1255.
37. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. 2007. Development of the human infant intestinal microbiota. PLoS Biol. 5:e177. doi:10.1371/journal.pbio.0050177.
38. Pineiro M, et al. 2008. FAO technical meeting on prebiotics. J. Clin. Gastroenterol. 42(Suppl 3, Pt 2):S156-S159.
39. Prince GA, Curtis SJ, Yim KC, Porter DD. 2001. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J. Gen. Virol. 82:2881-2888.
40. Prince GA, Horswood RL, Berndt J, Suffin SC, Chanock RM. 1979.Respiratory syncytial virus infection in inbred mice. Infect. Immun. 26:764-766.
41. Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS. 2009. Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J. Virol. 83:3019-3028.
42. Sehrawat S, et al. 2010. Galectin-9/TIM-3 interaction regulates virusspecific primary and memory CD8 T cell response. PLoS Pathog.6:e1000882. doi:10.1371/journal.ppat.1000882
43. Sehrawat S, Suryawanshi A, Hirashima M, Rouse BT. 2009. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 182:3191-3201.
44. Shay DK, et al. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282:1440 -1446.
45. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. 2000. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161:1501-1507.
46. Simoes EA, et al. 2010. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J. Allergy Clin. Immunol. 126:256 -262.
47. Sin DD, Sutherland ER. 2008. Obesity and the lung: 4. Obesity and asthma. Thorax 63:1018-1023.
48. Smit JJ, et al. 2008. The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PLoS One 3:e1720. doi:10.1371/journal.pone.0001720.
49. Stark JM, et al. 2002. Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J. Med. Virol. 67:92-100.
50. Sung SS, et al. 2006. A major lung CD103 (alphaE)-beta7 integrinpositive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176:2161-2172.
51. Tanaka K, Sawamura S, Satoh T, Kobayashi K, Noda S. 2007. Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirus. J. Immunol. 178:5209-5216.
52. Turnbaugh PJ, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457:480-484.
53. van de Pol MA, Lutter R, Smids BS, Weersink EJ, van der Zee JS. 2011.Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 66:39-47.
54. A specific mixture of short-chain galactooligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy
55. van't Land B, et al. 2010. Regulatory T-cells have a prominent role in the immune modulated vaccine response by specific oligosaccharides. Vaccine 28:5711-5717.
56. Vos AP, Knol J, Stahl B, M'rabet L, Garssen J. 2010. Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response.Int. Immunopharmacol. 10:619-625.
57. Vos AP, et al. 2007. Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int. Immunopharmacol.7:1582-1587.
58. Wei B, et al. 2008. Resident enteric microbiota and CD8+T cells shape the abundance of marginal zone B cells. Eur. J. Immunol. 38:3411-3425.
59. Wei B, et al. 2010. Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J. Immunol. 184:1218-1226.
60. Winzler C, et al. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185:317-328.